Stearic Acid
CAS 57-11-4
Stearic Acid (CAS 57-11-4) is a pharmaceutical compound with 6 bioactivity targets and 694 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | AC50 | 26570.146875 nM | 32 | - |
| - | Potency | 15810.254545454547 nM | 11 | - |
| - | IC50 | 12407.517142857143 nM | 6 | - |
| - | MIC | 209.33333333333334 ug.mL-1 | 3 | - |
| - | Ki | 4010 nM | 2 | - |
| - | EC50 | 40000 nM | 1 | - |
| - | Kd | 80000 nM | 1 | - |
| - | MIC | 300000 nM | 1 | - |
| Peroxisome proliferator-activated receptor alpha Nuclear hormone receptor |
IC50 | 5.96 | - | Homo sapiens |
| Peroxisome proliferator-activated receptor gamma Nuclear hormone receptor |
IC50 | 4.52 | - | Homo sapiens |
| Tyrosine-protein phosphatase non-receptor type 1 Enzyme |
IC50 | 5.64 | - | Homo sapiens |
| Fatty acid-binding protein, adipocyte Cytosolic other |
Kd | 4.1 | - | Homo sapiens |
| Peroxisome proliferator-activated receptor delta Nuclear hormone receptor |
IC50 | 5.22 | - | Homo sapiens |
| Acetylcholinesterase Enzyme |
Ki | 5.44 | - | Electrophorus electricus |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| STEARIC ACID | 1310551 | SU | MTHSPL |
| Stearic Acid | 1310551 | SU | MTHSPL |
| Stearic acid | 1310551 | SU | MTHSPL |
| stearic acid | 1310551 | SU | MTHSPL |
| stearic acid | 1310551 | PIN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Stearic Acid used for in pharmaceutical contexts?
Stearic Acid (CAS 57-11-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Stearic Acid?
Stearic Acid has 694 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Allergic sinusitis, Alopecia, Bronchitis, COVID-19, Conjunctivitis. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Stearic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Stearic Acid with EU status "permitted".
What clinical phase is Stearic Acid in?
No phase 1-4 clinical development badge is rendered for Stearic Acid because the matched compound identifier rows do not contain a max-phase value.
What bioactivity targets are documented for Stearic Acid?
Stearic Acid has 14 bioactivity rows in this page query. Rendered target entries include Peroxisome proliferator-activated receptor alpha, Peroxisome proliferator-activated receptor gamma, Tyrosine-protein phosphatase non-receptor type 1, Fatty acid-binding protein, adipocyte, Peroxisome proliferator-activated receptor delta.